Operating Profit Changement
Abbvie ABBV:US $ 3753M 498M
Acadia Pharmaceuticals ACAD:US $ -67.16M 18.74M
Acorda Therapeutics ACOR:US $ 16.04M 25.59M
Adamas Pharmaceuticals ADMS:US $ -14977000 6.21M
Aerie Pharmaceuticals AERI:US $ -35.59M 1.99M
Aptinyx Inc APTX:US $ -11423000 1.22M
Biocryst Pharmaceuticals BCRX:US $ -54.42M 11.55M
Flexion Therapeutics FLXN:US $ -18870000 8.4M
GlaxoSmithKline GSK:LN 1.06B 797M
Glaxosmithkline GSK:US $ 1061M 797M
Gw Pharmaceuticals GWPH:US $ -22.81M 10.09M
Heron Therapeutics HRTX:US $ -61.3M 2.91M
Intra Cellular Therapies ITCI:US $ -61.33M 5.4M
Marinus Pharmaceuticals MRNS:US $ -15.7M 0.18M
Merk MRK:US $ -2249M 5365M
Neurocrine Biosciences NBIX:US $ 53.4M 97.7M
Novartis NOVN:VX 2.64B 232M
Prothena PRTA:US -30308000 538K
Revance Therapeutics RVNC:US $ -77969000 841K
Teva Pharmaceutical TEVA:IT 405M 4.75B
Zogenix ZGNX:US $ -67.78M 6.22M



Adamas Pharmaceuticals Le Bénéfice D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2021.